术前EQ-5D视觉模拟评分与肺癌切除术后无复发生存期的关联
该单中心回顾性研究纳入200例2015年1月至2018年4月间接受完全性切除的临床I期非小细胞肺癌患者,术前采用EQ-5D-5L评估生活质量。中位随访6.0年,5年无复发生存率为82.2%(42例事件)。术前EQ-5D VAS评分较低与更差的无复发生存期相关,且主要由复发风险增加驱动,而非其他原因死亡。
要点
- 术前EQ-5D VAS每降低1单位,RFS的HR为1.020(95%CI 1.002-1.039)。
- VAS≤55与更差RFS相关(HR 2.762,95%CI 1.271-6.005;p=0.010)。
- 竞争风险分析中VAS≤55组肺癌复发风险更高(调整HR 3.45,95%CI 1.09-10.96)。
核心结论
- 术前EQ-5D VAS评分较低与临床I期NSCLC患者更差的无复发生存期相关,主要由复发增加驱动而非其他原因死亡。
研究设计与样本
- 单中心回顾性研究,纳入200例2015年1月至2018年4月间接受完全性切除的临床I期NSCLC患者,术前采用EQ-5D-5L评估生活质量。
主要发现
- 中位随访6.0年,5年RFS率为82.2%(42例事件)。
- 单因素Cox分析中,EQ-5D VAS每降低1单位,RFS的HR为1.020(95%CI 1.002-1.039)。
- EQ-5D VAS≤55与更差RFS相关(HR 2.762,95%CI 1.271-6.005;p=0.010)。
- 调整Performance Status和改良Glasgow预后评分后,VAS≤55组肺癌复发风险显著更高(调整HR 3.45,95%CI 1.09-10.96),而两组其他原因死亡率相当。
临床怎么用
- 术前EQ-5D VAS评分可作为临床I期NSCLC患者术后复发风险的辅助分层信息。
- VAS≤55的患者可能需要更密切的术后随访监测。
局限性
- 单中心回顾性设计,样本量200例,可能存在选择偏倚。
- EQ-5D VAS为自报整体健康状况,易受主观因素影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To investigate the prognostic impact of preoperative self-reported global health status, assessed with the EQ-5D visual analogue scale (VAS), on recurrence-free survival (RFS) in patients undergoing resection for clinical stage I non-small cell lung cancer (NSCLC). METHODS: This retrospective study included 200 patients from a single-center quality-of-life assessment cohort who underwent complete resection for clinical stage I NSCLC between January 2015 and April 2018. Preoperative QOL was assessed with the EQ-5D-5L. RFS was analyzed with the Kaplan-Meier method and the Cox proportional hazards model. Competing risk analysis was performed to distinguish recurrence from mortality due to other causes. RESULTS: The median follow-up was 6.0 years and the 5-year RFS rate was 82.2% (42 events). On univariable Cox analysis for RFS, the hazard ratio (HR) per 1-unit decrease in EQ-5D VAS scores was 1.020(95% CI 1.002-1.039). An EQ-5D VAS score ≤55 was also associated with worse RFS (HR 2.762, 95% CI 1.271-6.005; p = 0.010). On competing risk analysis adjusting for Performance Status, and modified Glasgow Prognostic Score, the recurrence risk of lung cancer was significantly higher in the VAS ≤55 group (adjusted HR 3.45, 95% CI 1.09-10.96), whereas mortality from other causes was comparable between the 2 VAS groups. CONCLUSIONS: Lower preoperative EQ-5D VAS scores were associated with poorer recurrence-free survival in patients with clinical stage I NSCLC, driven primarily by increased recurrence rather than by other-cause mortality.
引用
- Ichimura H, Kobayashi K, Gosho M, et al. Association between preoperative EQ-5D visual analogue scale score and recurrence-free survival after lung cancer resection. Interdiscip Cardiovasc Thorac Surg. 2026. PMID: 42813973. doi:10.1093/icvts/ivag271
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。